Post job

Ziopharm oncology main competitors are Genentech, Pharmacyclics, and Amicus Therapeutics.

Competitor Summary. See how Ziopharm oncology compares to its main competitors:

  • Genentech has the most employees (13,638).
  • Employees at Genentech earn more than most of the competitors, with an average yearly salary of $97,473.
  • The oldest company is American Air Liquide Holdings, founded in 1902.
Work at Ziopharm oncology?
Share your experience

Ziopharm oncology vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
2005
3.9
Boston, MA1$6.4M48
Opexa Therapeutics
1986
3.9
The Woodlands, TX3$2.9M23
1902
4.8
Houston, TX7$5.3B8,197
1981
4.6
Tustin, CA1$57.6M321
1991
4.9
Sunnyvale, CA1$235.0M607
2002
4.6
Cranbury, NJ2$528.3M508
1976
4.5
South San Francisco, CA5$166.9M13,638

Rate how well Ziopharm oncology differentiates itself from its competitors.

Zippia waving zebra

Ziopharm oncology salaries vs competitors

Among Ziopharm oncology competitors, employees at Genentech earn the most with an average yearly salary of $97,473.

Compare Ziopharm oncology salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Ziopharm oncology
$46,986$22.59-
Opexa Therapeutics
$58,501$28.13-
American Air Liquide Holdings
$83,932$40.35-
Peregrine Pharmaceuticals
$61,658$29.64-
Pharmacyclics
$97,383$46.82-
Amicus Therapeutics
$88,124$42.37-

Compare Ziopharm oncology job title salaries vs competitors

CompanyHighest salaryHourly salary
Ziopharm oncology
$32,560$15.65
American Air Liquide Holdings
$42,674$20.52
Opexa Therapeutics
$39,404$18.94
Genentech
$39,125$18.81
Peregrine Pharmaceuticals
$37,665$18.11
Pharmacyclics
$35,733$17.18
Amicus Therapeutics
$33,535$16.12

Do you work at Ziopharm oncology?

Is Ziopharm oncology able to compete effectively with similar companies?

Ziopharm oncology jobs

Ziopharm oncology demographics vs competitors

Compare gender at Ziopharm oncology vs competitors

Job titleMaleFemale
Pharmacyclics42%58%
Amicus Therapeutics43%57%
Ziopharm oncology50%50%
Genentech54%46%
American Air Liquide Holdings61%39%

Compare race at Ziopharm oncology vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
73%9%6%10%2%
6.5
47%17%9%21%6%
8.8
48%11%11%25%5%
9.2
45%20%7%22%6%
9.8
43%20%6%24%7%
9.6

Ziopharm oncology and similar companies CEOs

CEOBio
John Francis Crowley
Amicus Therapeutics

John Francis Crowley (born April 7, 1967) is an American biotechnology executive and entrepreneur and the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme Corporation, and founded Orexigen Therapeutics. In 2006, he was profiled in the book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children by Geeta Anand. In 2010, Crowley released his memoir, Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. Crowley and his family were the inspiration for the movie Extraordinary Measures starring Harrison Ford and Brendan Fraser in 2010.

David McWilliams
Opexa Therapeutics

Alexander Hardy
Genentech

Alexander Hardy is the CEO of Genentech. Hardy, who joined Genentech in 2005, has served as CEO since March 1, 2019. He previously served as head of global product Strategy for Roche Pharmaceuticals. Previously, he headed up Asia Pacific for Roche's pharma outfit.

Ziopharm oncology competitors FAQs

Search for jobs